United Kingdom, June’21: The new UK Company is going to offer clinical development and distribution of new medical products to fulfill the needs of clinics and hospital.
The company is specially focusing on Cannabis innovation and has established partnership with manufacturers, who are providing trustworthy, cost-effective and clinically validated product. The main aim is to provide clients and their patients with full services access to the highest quality cannabis derived products across UK, EU; and in the coming months they are planning to supply into the world market.
With the new launch of Cannabis in the market, the UK company wants to transform the market and make people believe that they can fulfill the needs of the medical cannabis market by offering the best products, expert services and consultation to exceed the expectations of suppliers, partners and patients.
Robin Emerson, a co-founder said ‘Cannabis may produce more products processes and solutions that are clinically validated, safe, sustainable and cost-effective, so more patients can benefit from this transformative plant.’ The UK company’s purpose is to transform the medical cannabis market by providing quality products without any side effects.
Elite Pharmaco, founded by “cannabis veterans” such as Robin Emerson and Liam McGreevy will reportedly focus on providing a consistent supply of high-quality and safe medical cannabis products, and cutting-edge supply solutions to improve the patient and healthcare professional experience.
We aim at keeping our subscribers up-to-date with news & insights, regulation and legislation reforms, and industry updates within the CBD industry. Visit now for more updates https://canex.co.uk/ .
About Company:
We are Canex, a leading UK-based portal for CBD news. With the CBD industry exploding all around the world, we aim to bring you everything you need to know; from both home and abroad. The CBD industry has become one of the fastest growing health and wellness industries in recent years. We provide the most up-to-date information about the industry, in order to keep the general public well-educated in line with this growth.